S230: CD22 CAR T CELL THERAPY IS SAFE AND EFFECTIVE IN PATIENTS WITH LARGE B CELL LYMPHOMA WHO HAVE RELAPSED AFTER CD19 CAR T CELL THERAPY von Frank, Matthew J., Baird, John, Kramer, Anne, Patel, Shabnum, Sahaf, Bita, Craig, Juliana, Crawford, Emma, Younes, Sheren, Oak, Jean, Natkunan, Yasodha, Spiegel, Jay, Ehlinger, Zachary, Chinnasamy, Harshini, Reynolds, Warren, Srinagesh, Hrishi, Su, Yi‐Jiun, Egeler, Emily, Feldman, Steven, Mackall, Crystal, Muffly, Lori, Miklos, David

Volltext